A glimpse of the current research on COVID-19

As the world is fighting COVID-19, laymen may be wondering how the research on COVID-19 is going and what are the current findings and outputs.

In this platform, you can find and read updated list of current research happening around the world on novel coronavirus COVID-19

Please note that this is just the list of relevant research publications and links to other platforms. If anyone wants to read any article from this list, they may either click the link, or if there is no link, they may google and find the article.

Considering the impact COVID-19 has on humans around the world and countries, many of the publishers are making most of these articles open so that anyone can read it from anywhere around the globe.

From Nature Publishing Group

From Science Magazine

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

The Lancet

Current research on COVID-19^1-231

More research on COVID^232-455

Other list of publications

1        Zumla, A. & Niederman, M. S. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security. Current opinion in pulmonary medicine, doi:10.1097/mcp.0000000000000676 (2020).

2        Zhuang, G. H. et al. [Potential false-positive rate among the ‘asymptomatic infected individuals’ in close contacts of COVID-19 patients]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 41, 485-488, doi:10.3760/cma.j.cn112338-20200221-00144 (2020).

3        Zhu, Z. W. et al. [Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics]. Zhonghua xin xue guan bing za zhi 48, E007, doi:10.3760/cma.j.cn112148-20200218-00093 (2020).

4        Zhu, Y. et al. Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19). The Journal of infection, doi:10.1016/j.jinf.2020.02.022 (2020).

5        Zhu, W. J. et al. [The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 42, E008, doi:10.3760/cma.j.cn112152-20200303-00166 (2020).

6        Zhou, Y. H. et al. Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial. Chin Med J (Engl), doi:10.1097/cm9.0000000000000791 (2020).

7        Zhou, S., Wang, Y., Zhu, T. & Xia, L. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. AJR. American journal of roentgenology, 1-8, doi:10.2214/ajr.20.22975 (2020).

8        Zhou, P., Huang, Z., Xiao, Y., Huang, X. & Fan, X. G. Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus. Infect Control Hosp Epidemiol, 1-4, doi:10.1017/ice.2020.60 (2020).

9        Zhou, L., Liu, K. & Liu, H. G. [Cause analysis and treatment strategies of “recurrence” with novel coronavirus pneumonia (covid-19) patients after discharge from hospital]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 43, E028, doi:10.3760/cma.j.cn112147-20200229-00219 (2020).

10      Zhao, Z., Bai, H., Duan, J. C. & Wang, J. [Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 42, E007, doi:10.3760/cma.j.cn112152-20200228-00146 (2020).

11      Zhao, W., Zhong, Z., Xie, X., Yu, Q. & Liu, J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR. American journal of roentgenology, 1-6, doi:10.2214/ajr.20.22976 (2020).

12      Zhao, S. et al. Serial interval in determining the estimation of reproduction number of the novel coronavirus disease (COVID-19) during the early outbreak. Journal of travel medicine, doi:10.1093/jtm/taaa033 (2020).

13      Zhao, S. et al. The time-varying serial interval of the coronavirus disease (COVID-19) and its gender-specific difference: A data-driven analysis using public surveillance data in Hong Kong and Shenzhen, China from January 10 to February 15, 2020. Infect Control Hosp Epidemiol, 1-8, doi:10.1017/ice.2020.64 (2020).

14      Zhao, D. et al. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa247 (2020).

15      Zhang, T. et al. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Science China. Life sciences, doi:10.1007/s11427-020-1660-2 (2020).

16      Zhang, S., Diao, M. Y., Duan, L., Lin, Z. & Chen, D. The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges. Intensive care medicine, doi:10.1007/s00134-020-05977-9 (2020).

17      Zhang, J., Wang, S. & Xue, Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol, doi:10.1002/jmv.25742 (2020).

18      Young, B. E. et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. Jama, doi:10.1001/jama.2020.3204 (2020).

19      Yao, X. et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa237 (2020).

20      Yao, N. et al. [Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 28, E003, doi:10.3760/cma.j.cn501113-20200226-00070 (2020).

21      Yang, Y. et al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of autoimmunity, 102434, doi:10.1016/j.jaut.2020.102434 (2020).

22      Yang, L., Xu, H. Y. & Wang, Y. [Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 42, E006, doi:10.3760/cma.j.cn112152-20200229-00152 (2020).

23      Yan, R. et al. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science (New York, N.Y.), doi:10.1126/science.abb2762 (2020).

24      Xu, Y. Unveiling the Origin and Transmission of 2019-nCoV. Trends in microbiology 28, 239-240, doi:10.1016/j.tim.2020.02.001 (2020).

25      Xu, X. W. et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. Bmj-British Medical Journal 368, doi:10.1136/bmj.m606 (2020).

26      Xu, J., Shi, P. Y., Li, H. & Zhou, J. Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential. ACS infectious diseases, doi:10.1021/acsinfecdis.0c00052 (2020).

27      Xiong, Y. et al. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Investigative radiology, doi:10.1097/rli.0000000000000674 (2020).

28      Xie, C. et al. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, doi:10.1016/j.ijid.2020.02.050 (2020).

29      Xiao, H., Zhang, Y., Kong, D., Li, S. & Yang, N. The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease 2019 (COVID-19) in January and February 2020 in China. Medical science monitor : international medical journal of experimental and clinical research 26, e923549, doi:10.12659/msm.923549 (2020).

30      Xia, W. et al. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatric pulmonology, doi:10.1002/ppul.24718 (2020).

31      Wu, Y. C., Chen, C. S. & Chan, Y. J. The outbreak of COVID-19: An overview. Journal of the Chinese Medical Association : JCMA 83, 217-220, doi:10.1097/jcma.0000000000000270 (2020).

32      Wu, Y. et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet, doi:10.1016/s0140-6736(20)30557-2 (2020).

33      Wu, X. et al. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China. Emerg Infect Dis 26, doi:10.3201/eid2606.200299 (2020).

34      Wu, J. et al. [Novel coronavirus pneumonia (COVID-19) CT distribution and sign features]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 43, E030, doi:10.3760/cma.j.cn112147-20200217-00106 (2020).

35      Wong, J. et al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Canadian journal of anaesthesia = Journal canadien d’anesthesie, doi:10.1007/s12630-020-01620-9 (2020).

36      Won, J. et al. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19). Experimental neurobiology, doi:10.5607/en20009 (2020).

37      Wilder-Smith, A., Chiew, C. J. & Lee, V. J. Can we contain the COVID-19 outbreak with the same measures as for SARS? The Lancet. Infectious diseases, doi:10.1016/s1473-3099(20)30129-8 (2020).

38      Wen, F. et al. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2. The Journal of infection, doi:10.1016/j.jinf.2020.02.027 (2020).

39      Wang, Z. F. et al. [Thinking on Clinical rational use of TCM injection in the treatment of novel coronavirus pneumonia (COVID-19)]. Zhonghua yi xue za zhi 100, E016, doi:10.3760/cma.j.issn.cn112137-20200221-00388 (2020).

40      Wang, Y., Wang, Y., Chen, Y. & Qin, Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol, doi:10.1002/jmv.25748 (2020).

41      Wang, X. et al. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa200 (2020).

42      Wang, S. et al. A case report of neonatal COVID-19 infection in China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa225 (2020).

43      Wang, L. et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition). Annals of translational medicine 8, 47, doi:10.21037/atm.2020.02.20 (2020).

44      Wang, J., Zhou, M. & Liu, F. Exploring the reasons for healthcare workers infected with novel coronavirus disease 2019 (COVID-19) in China. The Journal of hospital infection, doi:10.1016/j.jhin.2020.03.002 (2020).

45      Wang, H. et al. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China. Cell discovery 6, 10, doi:10.1038/s41421-020-0148-0 (2020).

46      Wang, D. et al. [Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China]. Zhonghua er ke za zhi = Chinese journal of pediatrics 58, E011, doi:10.3760/cma.j.cn112140-20200225-00138 (2020).

47      Wang, C. et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. International journal of environmental research and public health 17, doi:10.3390/ijerph17051729 (2020).

48      Walls, A. C. et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell, doi:10.1016/j.cell.2020.02.058 (2020).

49      Touret, F. & de Lamballerie, X. Of chloroquine and COVID-19. Antiviral Res 177, 104762, doi:10.1016/j.antiviral.2020.104762 (2020).

50      Ton, A. T., Gentile, F., Hsing, M., Ban, F. & Cherkasov, A. Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds. Molecular informatics, doi:10.1002/minf.202000028 (2020).

51      Tian, X. L. et al. [The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 43, E035, doi:10.3760/cma.j.cn112147-20200221-00136 (2020).

52      Thomson, G. A. Where are we now with COVID-19? International journal of clinical practice, e13497, doi:10.1111/ijcp.13497 (2020).

53      Tao, J. et al. Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department. The British journal of dermatology, doi:10.1111/bjd.19011 (2020).

54      Tao, F. B. [Healing the schism between public health and medicine, promoting the integration of prevention and treatment]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 54, E024, doi:10.3760/cma.j.cn112150-20200304-00246 (2020).

55      Tang, A. et al. Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China. Emerg Infect Dis 26, doi:10.3201/eid2606.200301 (2020).

56      Sun, Z., Thilakavathy, K., Kumar, S. S., He, G. & Liu, S. V. Potential Factors Influencing Repeated SARS Outbreaks in China. International journal of environmental research and public health 17, doi:10.3390/ijerph17051633 (2020).

57      Stoffel, C. et al. The ongoing crises in China illustrate that the assessment of epidemics in isolation is no longer sufficient. Transboundary and emerging diseases, doi:10.1111/tbed.13536 (2020).

58      Spiteri, G. et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25, doi:10.2807/1560-7917.es.2020.25.9.2000178 (2020).

59      Shrestha, R., Shrestha, S., Khanal, P. & Bhuvan, K. C. Nepal’s First Case of COVID-19 and public health response. Tree physiology, doi:10.1093/treephys/tpaa024 (2020).

60      Shen, Z. et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa203 (2020).

61      Sheahan, T. P. et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications 11, 222, doi:10.1038/s41467-019-13940-6 (2020).

62      Shanmugaraj, B., Siriwattananon, K., Wangkanont, K. & Phoolcharoen, W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pacific journal of allergy and immunology, doi:10.12932/ap-200220-0773 (2020).

63      Shang, L., Zhao, J., Hu, Y., Du, R. & Cao, B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 395, 683-684, doi:10.1016/s0140-6736(20)30361-5 (2020).

64      Shang, J. et al. Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Pathog 16, e1008392, doi:10.1371/journal.ppat.1008392 (2020).

65      Sahu, K. K., Mishra, A. K. & Lal, A. Novel coronavirus (2019-nCoV): Update on 3rd Coronavirus Outbreak of 21st Century. QJM : monthly journal of the Association of Physicians, doi:10.1093/qjmed/hcaa081 (2020).

66      Ruan, Z. R., Gong, P., Han, W., Huang, M. Q. & Han, M. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days. Chin Med J (Engl), doi:10.1097/cm9.0000000000000788 (2020).

67      Rothe, C. et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal of Medicine 382, 970-971, doi:10.1056/NEJMc2001468 (2020).

68      Rodriguez-Morales, A. J. et al. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel medicine and infectious disease, 101613, doi:10.1016/j.tmaid.2020.101613 (2020).

69      Reusken, C. B. et al. Authors’ response: Plenty of coronaviruses but no SARS-CoV-2. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25, doi:10.2807/1560-7917.es.2020.25.8.2000197 (2020).

70      Ren, S. Y., Gao, R. D. & Chen, Y. L. Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic. World journal of clinical cases 8, 652-657, doi:10.12998/wjcc.v8.i4.652 (2020).

71      Rello, J. et al. Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China. Anaesthesia, critical care & pain medicine, doi:10.1016/j.accpm.2020.03.001 (2020).

72      Razai, M. S., Doerholt, K., Ladhani, S. & Oakeshott, P. Coronavirus disease 2019 (covid-19): a guide for UK GPs. BMJ (Clinical research ed.) 368, m800, doi:10.1136/bmj.m800 (2020).

73      Rao, A. & Vazquez, J. A. Identification of COVID-19 Can be Quicker through Artificial Intelligence framework using a Mobile Phone-Based Survey in the Populations when Cities/Towns Are Under Quarantine. Infect Control Hosp Epidemiol, 1-18, doi:10.1017/ice.2020.61 (2020).

74      Qing, M. X. et al. Emergency management of the prevention and control of novel coronavirus pneumonia in specialized branches of hospital. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, doi:10.1111/acem.13958 (2020).

75      Qin, C. et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa248 (2020).

76      Porcheddu, R., Serra, C., Kelvin, D., Kelvin, N. & Rubino, S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. Journal of infection in developing countries 14, 125-128, doi:10.3855/jidc.12600 (2020).

77      Poon, L. C. et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, doi:10.1002/uog.22013 (2020).

78      Pfefferle, S., Reucher, S., Norz, D. & Lutgehetmann, M. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25, doi:10.2807/1560-7917.es.2020.25.9.2000152 (2020).

79      Peng, Y. D. et al. [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV]. Zhonghua xin xue guan bing za zhi 48, E004, doi:10.3760/cma.j.cn112148-20200220-00105 (2020).

80      Peng, X. et al. Transmission routes of 2019-nCoV and controls in dental practice. International Journal of Oral Science 12, 9, doi:10.1038/s41368-020-0075-9 (2020).

81      Peng, P. W. H., Ho, P. L. & Hota, S. S. Outbreak of a new coronavirus: what anaesthetists should know. British journal of anaesthesia, doi:10.1016/j.bja.2020.02.008 (2020).

82      Pan, C. et al. [Noninvasive Respiratory Support for Novel Coronavirus Pneumonia: Enough is Enough]. Zhonghua nei ke za zhi 59, E006, doi:10.3760/cma.j.issn.0578-1426.2020.0006 (2020).

83      Ong, S. W. X. et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. Jama, doi:10.1001/jama.2020.3227 (2020).

84      Okada, P. et al. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25, doi:10.2807/1560-7917.es.2020.25.8.2000097 (2020).

85      Nishiura, H., Linton, N. M. & Akhmetzhanov, A. R. Serial interval of novel coronavirus (COVID-19) infections. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, doi:10.1016/j.ijid.2020.02.060 (2020).

86      Nishiura, H. Backcalculating the Incidence of Infection with COVID-19 on the Diamond Princess. Journal of clinical medicine 9, doi:10.3390/jcm9030657 (2020).

87      More, G. D., Dunowska, M., Acke, E. & Cave, N. J. A serological survey of canine respiratory coronavirus in New Zealand. New Zealand Veterinary Journal 68, 54-59, doi:10.1080/00480169.2019.1667282 (2020).

88      Moorthy, V., Henao Restrepo, A. M., Preziosi, M. P. & Swaminathan, S. Data sharing for novel coronavirus (COVID-19). Bulletin of the World Health Organization 98, 150, doi:10.2471/blt.20.251561 (2020).

89      Meo, S. A. et al. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. European review for medical and pharmacological sciences 24, 2012-2019, doi:10.26355/eurrev_202002_20379 (2020).

90      Meng, L., Hua, F. & Bian, Z. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine. Journal of dental research, 22034520914246, doi:10.1177/0022034520914246 (2020).

91      Maxwell, D. N., Perl, T. M. & Cutrell, J. B. “The Art of War” in the Era of Coronavirus Disease 2019 (COVID-19). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa229 (2020).

92      Maxmen, A. The race to unravel the biggest coronavirus outbreak in the United States. Nature Communications 579 181–182 (2020).

93      Marty, A. M. & Jones, M. K. The novel Coronavirus (SARS-CoV-2) is a one health issue. One Health 9, 100123, doi:10.1016/j.onehlt.2020.100123 (2020).

94      Martinez, M. A. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrobial agents and chemotherapy, doi:10.1128/aac.00399-20 (2020).

95      Marchand-Senecal, X. et al. Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa227 (2020).

96      Malta, M., Rimoin, A. W. & Strathdee, S. A. The coronavirus 2019-nCoV epidemic: Is hindsight 20/20? EClinicalMedicine 20, 100289, doi:10.1016/j.eclinm.2020.100289 (2020).

97      Mallapaty, S. Why does the coronavirus spread so easily between people? Nature 579 183–183 (2020).

98      Maffioli, E. M. How Is the World Responding to the 2019 Coronavirus Disease Compared with the 2014 West African Ebola Epidemic? The Importance of China as a Player in the Global Economy. The American journal of tropical medicine and hygiene, doi:10.4269/ajtmh.20-0135 (2020).

99      Ma, K., Chen, T., Han, M. F., Guo, W. & Ning, Q. [Management and clinical thinking of Coronavirus Disease 2019]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 28, E002, doi:10.3760/cma.j.issn.1007-3418.2020.0002 (2020).

100    Lupia, T. et al. 2019-novel coronavirus outbreak: A new challenge. Journal of global antimicrobial resistance, doi:10.1016/j.jgar.2020.02.021 (2020).

101    Luo, S. H. et al. A confirmed asymptomatic carrier of 2019 novel coronavirus (SARS-CoV-2). Chin Med J (Engl), doi:10.1097/cm9.0000000000000798 (2020).

102    Lu, R. J. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565-574, doi:10.1016/s0140-6736(20)30251-8 (2020).

103    Lu, Q. & Shi, Y. Coronavirus disease (COVID-19) and neonate: What neonatologist need to know. J Med Virol, doi:10.1002/jmv.25740 (2020).

104    Lu, H. Z., Stratton, C. W. & Tang, Y. W. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Journal of Medical Virology 92, 401-402, doi:10.1002/jmv.25678 (2020).

105    Lu, H., Stratton, C. W. & Tang, Y. W. The Wuhan SARS-CoV-2 – What’s Next for China. J Med Virol, doi:10.1002/jmv.25738 (2020).

106    Lombardi, A. et al. Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer. The Journal of hospital infection, doi:10.1016/j.jhin.2020.03.003 (2020).

107    Liu, Y., Chen, H., Tang, K. & Guo, Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. The Journal of infection, doi:10.1016/j.jinf.2020.02.028 (2020).

108    Liu, W., Zhu, H. L. & Duan, Y. Effective Chemicals against Novel Coronavirus (COVID-19) in China. Current topics in medicinal chemistry, doi:10.2174/1568026620999200305145032 (2020).

109    Liu, W. et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl), doi:10.1097/cm9.0000000000000775 (2020).

110    Liu, R. et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clinica chimica acta; international journal of clinical chemistry, doi:10.1016/j.cca.2020.03.009 (2020).

111    Liu, J. et al. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis 26, doi:10.3201/eid2606.200239 (2020).

112    Lippi, G. & Plebani, M. Laboratory abnormalities in patients with COVID-2019 infection. Clinical chemistry and laboratory medicine, doi:10.1515/cclm-2020-0198 (2020).

113    Lippi, G. & Plebani, M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clinica chimica acta; international journal of clinical chemistry, doi:10.1016/j.cca.2020.03.004 (2020).

114    Ling, Y. et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl), doi:10.1097/cm9.0000000000000774 (2020).

115    Ling, C. Q. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of integrative medicine, doi:10.1016/j.joim.2020.02.004 (2020).

116    Lin, Q. et al. A conceptual model for the outbreak of Coronavirus disease 2019 (COVID-19) in Wuhan, China with individual reaction and governmental action. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, doi:10.1016/j.ijid.2020.02.058 (2020).

117    Lin, C. et al. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease. Clinical imaging 63, 7-9, doi:10.1016/j.clinimag.2020.02.008 (2020).

118    Lillie, P. J. et al. Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission. The Journal of infection, doi:10.1016/j.jinf.2020.02.020 (2020).

119    Liew, M. F., Siow, W. T., MacLaren, G. & See, K. C. Preparing for COVID-19: early experience from an intensive care unit in Singapore. Critical care (London, England) 24, 83, doi:10.1186/s13054-020-2814-x (2020).

120    Li, Y. et al. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect Dis 26, doi:10.3201/eid2606.200287 (2020).

121    Li, Y. & Xia, L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. AJR. American journal of roentgenology, 1-7, doi:10.2214/ajr.20.22954 (2020).

122    Li, W. et al. Protocol for the development of a rapid advice guideline for prevention, management and care of children with 2019 novel coronavirus infection. Annals of palliative medicine, doi:10.21037/apm.2020.02.33 (2020).

123    Li, W., Cui, H., Li, K., Fang, Y. & Li, S. Chest computed tomography in children with COVID-19 respiratory infection. Pediatr Radiol, doi:10.1007/s00247-020-04656-7 (2020).

124    Li, L. Q. et al. 2019 novel coronavirus patients’ clinical characteristics, discharge rate and fatality rate of meta-analysis. J Med Virol, doi:10.1002/jmv.25757 (2020).

125    Li, G. & De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature reviews. Drug discovery 19, 149-150, doi:10.1038/d41573-020-00016-0 (2020).

126    Lee, I. K. et al. Effective strategies to prevent coronavirus disease-2019 (COVID-19) outbreak in hospital. The Journal of hospital infection, doi:10.1016/j.jhin.2020.02.022 (2020).

127    Layne, S. P., Hyman, J. M., Morens, D. M. & Taubenberger, J. K. New coronavirus outbreak: Framing questions for pandemic prevention. Science translational medicine 12, doi:10.1126/scitranslmed.abb1469 (2020).

128    Lauer, S. A. et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med, doi:10.7326/m20-0504 (2020).

129    Lake, M. A. What we know so far: COVID-19 current clinical knowledge and research. Clinical medicine (London, England), doi:10.7861/clinmed.2019-coron (2020).

130    Lai, T. H. T., Tang, E. W. H., Chau, S. K. Y., Fung, K. S. C. & Li, K. K. W. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, doi:10.1007/s00417-020-04641-8 (2020).

131    Kumar, S., Poonam & Rathi, B. Coronavirus Disease COVID-19: A New Threat to Public Health. Current topics in medicinal chemistry, doi:10.2174/1568026620999200305144319 (2020).

132    Kruse, R. L. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Research 9, 72, doi:10.12688/f1000research.22211.2 (2020).

133    Koonin, L. M. Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans. Journal of business continuity & emergency planning 13, 1-15 (2020).

134    Konrad, R. et al. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25, doi:10.2807/1560-7917.es.2020.25.9.2000173 (2020).

135    Klompas, M. Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible. Ann Intern Med, doi:10.7326/m20-0751 (2020).

136    Kim, J. M. et al. Identification of Coronavirus Isolated from a Patient in Korea with COVID-19. Osong public health and research perspectives 11, 3-7, doi:10.24171/j.phrp.2020.11.1.02 (2020).

137    Khot, W. Y. & Nadkar, M. Y. The 2019 Novel Coronavirus Outbreak – A Global Threat. The Journal of the Association of Physicians of India 68, 67-71 (2020).

138    Khan, S. et al. The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options. J Clin Microbiol, doi:10.1128/jcm.00187-20 (2020).

139    Kelman, M., Barrs, V. R., Norris, J. M. & Ward, M. P. Socioeconomic, geographic and climatic risk factors for canine parvovirus infection and euthanasia in Australia. Preventive Veterinary Medicine 174, doi:10.1016/j.prevetmed.2019.104816 (2020).

140    Kaplan, E. H. Containing 2019-nCoV (Wuhan) coronavirus. Health care management science, doi:10.1007/s10729-020-09504-6 (2020).

141    Kapata, N. et al. Is the Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic? – lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, doi:10.1016/j.ijid.2020.02.049 (2020).

142    Kannan, S., Shaik Syed Ali, P., Sheeza, A. & Hemalatha, K. COVID-19 (Novel Coronavirus 2019) – recent trends. European review for medical and pharmacological sciences 24, 2006-2011, doi:10.26355/eurrev_202002_20378 (2020).

143    Kamel Boulos, M. N. & Geraghty, E. M. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics. International journal of health geographics 19, 8, doi:10.1186/s12942-020-00202-8 (2020).

144    Jung, S. M. et al. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019-2020. Journal of clinical medicine 9, doi:10.3390/jcm9030637 (2020).

145    Johnson, H. C. et al. Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25, doi:10.2807/1560-7917.es.2020.25.9.2000202 (2020).

146    Jiang, F. et al. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). Journal of general internal medicine, doi:10.1007/s11606-020-05762-w (2020).

147    Ji, W., Wang, W., Zhao, X. F., Zai, J. J. & Li, X. G. Cross-species transmission of the newly identified coronavirus 2019-nCoV. Journal of Medical Virology 92, 433-440, doi:10.1002/jmv.25682 (2020).

148    Huh, S. How to train the health personnel for protecting themselves from novel coronavirus (COVID-19) infection during their patient or suspected case care. Journal of educational evaluation for health professions 17, 10, doi:10.3352/jeehp.2020.17.10 (2020).

149    Hu, Z. et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China. Life sciences, doi:10.1007/s11427-020-1661-4 (2020).

150    Holshue, M. L. et al. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine 382, 929-936, doi:10.1056/NEJMoa2001191 (2020).

151    Hoffmann, M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, doi:10.1016/j.cell.2020.02.052 (2020).

152    Henwood, A. F. Coronavirus disinfection in histopathology. Journal of histotechnology, 1-3, doi:10.1080/01478885.2020.1734718 (2020).

153    Hellewell, J. et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet. Global health, doi:10.1016/s2214-109x(20)30074-7 (2020).

154    Harcourt, J. et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. Emerg Infect Dis 26, doi:10.3201/eid2606.200516 (2020).

155    Han, Y. & Yang, H. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective. J Med Virol, doi:10.1002/jmv.25749 (2020).

156    Hageman, J. R. The Coronavirus Disease 2019 (COVID-19). Pediatric annals 49, e99-e100, doi:10.3928/19382359-20200219-01 (2020).

157    Gurwitz, D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug development research, doi:10.1002/ddr.21656 (2020).

158    Gorbalenya, A. E. et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, doi:10.1038/s41564-020-0695-z (2020).

159    Garnier-Crussard, A., Forestier, E., Gilbert, T. & Krolak-Salmon, P. Novel Coronavirus (COVID-19) Epidemic: What Are the Risks for Older Patients? Journal of the American Geriatrics Society, doi:10.1111/jgs.16407 (2020).

160    Fang, Y., Nie, Y. & Penny, M. Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis. J Med Virol, doi:10.1002/jmv.25750 (2020).

161    Fan, H. H. et al. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model. Chin Med J (Engl), doi:10.1097/cm9.0000000000000797 (2020).

162    Fan, C. et al. Prediction of Epidemic Spread of the 2019 Novel Coronavirus Driven by Spring Festival Transportation in China: A Population-Based Study. International journal of environmental research and public health 17, doi:10.3390/ijerph17051679 (2020).

163    Fahmi, M., Kubota, Y. & Ito, M. Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated with evolution of 2019-nCoV. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 81, 104272, doi:10.1016/j.meegid.2020.104272 (2020).

164    Elfiky, A. A. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life sciences 248, 117477, doi:10.1016/j.lfs.2020.117477 (2020).

165    Dong, L., Hu, S. & Gao, J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug discoveries & therapeutics 14, 58-60, doi:10.5582/ddt.2020.01012 (2020).

166    Diao, M., Zhang, S., Chen, D. & Hu, W. The novel coronavirus (COVID-19) infection in Hangzhou: An experience to share. Infect Control Hosp Epidemiol, 1-5, doi:10.1017/ice.2020.62 (2020).

167    Di Pierro, F., Bertuccioli, A. & Cavecchia, I. Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. Minerva gastroenterologica e dietologica, doi:10.23736/s1121-421x.20.02697-5 (2020).

168    Dey, S. K., Rahman, M. M., Siddiqi, U. R. & Howlader, A. Analyzing the epidemiological outbreak of COVID-19: A visual exploratory data analysis approach. J Med Virol, doi:10.1002/jmv.25743 (2020).

169    Dai, W. C. et al. CT Imaging and Differential Diagnosis of COVID-19. Canadian Association of Radiologists journal = Journal l’Association canadienne des radiologistes, 846537120913033, doi:10.1177/0846537120913033 (2020).

170    Cordes, A. K. & Heim, A. Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 125, 104305, doi:10.1016/j.jcv.2020.104305 (2020).

171    Conway, M. J. Identification of Coronavirus Sequences in Carp cDNA from Wuhan, China. J Med Virol, doi:10.1002/jmv.25751 (2020).

172    Colson, P. et al. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25, doi:10.2807/1560-7917.es.2020.25.8.2000171 (2020).

173    Chua, M. S. Q., Lee, J. C. S., Sulaiman, S. & Tan, H. K. From the frontlines of COVID-19 – How prepared are we as obstetricians: a commentary. BJOG : an international journal of obstetrics and gynaecology, doi:10.1111/1471-0528.16192 (2020).

174    Chopra, V., Toner, E., Waldhorn, R. & Washer, L. How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)? Ann Intern Med, doi:10.7326/m20-0907 (2020).

175    Chinazzi, M. et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science (New York, N.Y.), doi:10.1126/science.aba9757 (2020).

176    Chenoweth, A. M., Wines, B. D., Anania, J. C. & Mark Hogarth, P. Harnessing the immune system via FcgammaR function in immune therapy: A pathway to next-gen mAbs. Immunology and cell biology, doi:10.1111/imcb.12326 (2020).

177    Cheng, V. C. C. et al. Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol, 1-24, doi:10.1017/ice.2020.58 (2020).

178    Cheng, L. T. et al. Deja Vu or Jamais Vu? How the Severe Acute Respiratory Syndrome Experience Influenced a Singapore Radiology Department’s Response to the Coronavirus Disease (COVID-19) Epidemic. AJR. American journal of roentgenology, 1-5, doi:10.2214/ajr.20.22927 (2020).

179    Cheng, J. L. et al. [Epidemiological characteristics of novel coronavirus pneumonia in Henan]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 43, E027, doi:10.3760/cma.j.cn112147-20200222-00148 (2020).

180    Cheng, A. C. & Williamson, D. A. An outbreak of COVID-19 caused by a new coronavirus: what we know so far. The Medical journal of Australia, doi:10.5694/mja2.50530 (2020).

181    Chen, Z. L. et al. Distribution of the COVID-19 epidemic and correlation with population emigration from wuhan, China. Chin Med J (Engl), doi:10.1097/cm9.0000000000000782 (2020).

182    Chen, X. & Yu, B. First two months of the 2019 Coronavirus Disease (COVID-19) epidemic in China: real-time surveillance and evaluation with a second derivative model. Global health research and policy 5, 7, doi:10.1186/s41256-020-00137-4 (2020).

183    Chen, S. et al. [Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases]. Zhonghua bing li xue za zhi = Chinese journal of pathology 49, E005, doi:10.3760/cma.j.cn112151-20200225-00138 (2020).

184    Chen, R., Chen, J. & Meng, Q. T. Chest computed tomography images of early coronavirus disease (COVID-19). Canadian journal of anaesthesia = Journal canadien d’anesthesie, doi:10.1007/s12630-020-01625-4 (2020).

185    Chen, Q. et al. A report of clinical diagnosis and treatment of 9 cases of coronavirus disease 2019. J Med Virol, doi:10.1002/jmv.25755 (2020).

186    Chen, H. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 395, 809-815, doi:10.1016/s0140-6736(20)30360-3 (2020).

187    Chen, F. et al. [First case of severe childhood novel coronavirus pneumonia in China]. Zhonghua er ke za zhi = Chinese journal of pediatrics 58, 179-182, doi:10.3760/cma.j.issn.0578-1310.2020.03.003 (2020).

188    Chen, D. et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, doi:10.1016/j.ijid.2020.03.003 (2020).

189    Chan, J. F. W. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514-523, doi:10.1016/s0140-6736(20)30154-9 (2020).

190    Chan, J. F. et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol, doi:10.1128/jcm.00310-20 (2020).

191    Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C. & Di Napoli, R. in StatPearls     (StatPearls Publishing

StatPearls Publishing LLC., 2020).

192    Cao, Y. et al. Hospital Emergency Management Plan During the COVID-19 Epidemic. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, doi:10.1111/acem.13951 (2020).

193    Cao, Y. et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell discovery 6, 11, doi:10.1038/s41421-020-0147-1 (2020).

194    Cai, J. et al. Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020. Emerg Infect Dis 26, doi:10.3201/eid2606.200412 (2020).

195    Burke, R. M. et al. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 – United States, January-February 2020. MMWR. Morbidity and mortality weekly report 69, 245-246, doi:10.15585/mmwr.mm6909e1 (2020).

196    Brussow, H. The Novel Coronavirus – A Snapshot of Current Knowledge. Microbial biotechnology, doi:10.1111/1751-7915.13557 (2020).

197    Bordi, L. et al. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25, doi:10.2807/1560-7917.es.2020.25.8.2000170 (2020).

198    Bae, J. M. A Chinese Case of COVID-19 Did Not Show Infectivity During the Incubation Period: Based on an Epidemiological Survey. Journal of preventive medicine and public health = Yebang Uihakhoe chi, doi:10.3961/jpmph.20.048 (2020).

199    Ashour, H. M., Elkhatib, W. F., Rahman, M. M. & Elshabrawy, H. A. Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Pathogens (Basel, Switzerland) 9, doi:10.3390/pathogens9030186 (2020).

200    Arashiro, T., Furukawa, K. & Nakamura, A. COVID-19 in 2 Persons with Mild Upper Respiratory Symptoms on a Cruise Ship, Japan. Emerg Infect Dis 26, doi:10.3201/eid2606.200452 (2020).

201    Arabi, Y. M., Murthy, S. & Webb, S. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive care medicine, doi:10.1007/s00134-020-05955-1 (2020).

202    An, P., Song, P., Lian, K. & Wang, Y. CT Manifestations of Novel Coronavirus Pneumonia: A Case Report. Balkan medical journal, doi:10.4274/balkanmedj.galenos.2020.2020.2.15 (2020).

203    Amodio, E., Vitale, F., Cimino, L., Casuccio, A. & Tramuto, F. Outbreak of Novel Coronavirus (SARS-Cov-2): First Evidences From International Scientific Literature and Pending Questions. Healthcare (Basel, Switzerland) 8, doi:10.3390/healthcare8010051 (2020).

204    Al-Qaness, M. A. A., Ewees, A. A., Fan, H. & Abd El Aziz, M. Optimization Method for Forecasting Confirmed Cases of COVID-19 in China. Journal of clinical medicine 9, doi:10.3390/jcm9030674 (2020).

205    Al-Mandhari, A., Samhouri, D., Abubakar, A. & Brennan, R. Coronavirus Disease 2019 outbreak: preparedness and readiness of countries in the Eastern Mediterranean Region. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 26, 136-137, doi:10.26719/2020.26.2.136 (2020).

206    Allam, Z. & Jones, D. S. On the Coronavirus (COVID-19) Outbreak and the Smart City Network: Universal Data Sharing Standards Coupled with Artificial Intelligence (AI) to Benefit Urban Health Monitoring and Management. Healthcare (Basel, Switzerland) 8, doi:10.3390/healthcare8010046 (2020).

207    The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol, doi:10.1038/s41564-020-0695-z (2020).

208    [Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 43, E031, doi:10.3760/cma.j.cn112147-20200221-00138 (2020).

209    COVID-19, Australia: Epidemiology Report 5 (Reporting week ending 19:00 AEDT 29 February 2020). Communicable diseases intelligence (2018) 44, doi:10.33321/cdi.2020.44.20 (2020).

210    Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea. Osong public health and research perspectives 11, 8-14, doi:10.24171/j.phrp.2020.11.1.03 (2020).

211    Contact Transmission of COVID-19 in South Korea: Novel Investigation Techniques for Tracing Contacts. Osong public health and research perspectives 11, 60-63, doi:10.24171/j.phrp.2020.11.1.09 (2020).

212    [Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 43, E034, doi:10.3760/cma.j.cn112147-20200227-00201 (2020).

213    COVID-19, Australia: Epidemiology Report 6 (Reporting week ending 19:00 AEDT 7 March 2020). Communicable diseases intelligence (2018) 44, doi:10.33321/cdi.2020.44.21 (2020).

214    Naidenko, S. V., Erofeeva, M. N., Demina, T. S., Alekseicheva, I. A. & Pavlova, E. V. Comparative estimation of some immune parameters in three felid species. Russian Journal of Theriology 18, 1-11, doi:10.15298/rusjtheriol.18.1.01 (2019).

215    Kim, T. H. et al. Forecasting respiratory infectious outbreaks using ED-based syndromic surveillance for febrile ED visits in a Metropolitan City. American Journal of Emergency Medicine 37, 183-188, doi:10.1016/j.ajem.2018.05.007 (2019).

216    Johnson, B. A. et al. Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity. Journal of Virology 93, doi:10.1128/jvi.01282-19 (2019).

217    Holwerda, M. et al. Determining the Replication Kinetics and Cellular Tropism of Influenza D Virus on Primary Well-Differentiated Human Airway Epithelial Cells. Viruses-Basel 11, doi:10.3390/v11040377 (2019).

218    Hemida, M. G. & Alnaeem, A. Some One Health based control strategies for the Middle East respiratory syndrome coronavirus. One Health 8, doi:10.1016/j.onehlt.2019.100102 (2019).

219    He, L. et al. Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain. Viruses-Basel 11, doi:10.3390/v11020166 (2019).

220    Gong, Z. D. et al. Synchronous Detection of BPV and BVDV with Duplex Taqman qPCR Method. Acta Scientiae Veterinariae 47, doi:10.22456/1679-9216.93604 (2019).

221    Geng, J. J., Gong, Z. D., Li, Q. Y., Shen, X. Y. & Wei, S. C. Specific Detection of Bovine Coronavirus N Protein with TaqMan Probe qRT-PCR. Acta Scientiae Veterinariae 47, doi:10.22456/1679-9216.97156 (2019).

222    Gardner, E. G. et al. A case-crossover analysis of the impact of weather on primary cases of Middle East respiratory syndrome. Bmc Infectious Diseases 19, doi:10.1186/s12879-019-3729-5 (2019).

223    Deng, X. F. et al. Analysis of Coronavirus Temperature-Sensitive Mutants Reveals an Interplay between the Macrodomain and Papain-Like Protease Impacting Replication and Pathogenesis. Journal of Virology 93, doi:10.1128/jvi.02140-18 (2019).

224    Bekking, C. et al. Evaluation of bioaerosol samplers for the detection and quantification of influenza virus from artificial aerosols and influenza virus-infected ferrets. Influenza and Other Respiratory Viruses 13, 564-573, doi:10.1111/irv.12678 (2019).

225    Pyankov, O. V., Bodnev, S. A., Pyankova, O. G. & Agranovski, I. E. Survival of aerosolized coronavirus in the ambient air. Journal of Aerosol Science 115, 158-163, doi:10.1016/j.jaerosci.2017.09.009 (2018).

226    Prussin, A. J. et al. Survival of the Enveloped Virus Phi6 in Droplets as a Function of Relative Humidity, Absolute Humidity, and Temperature. Applied and Environmental Microbiology 84, doi:10.1128/aem.00551-18 (2018).

227    Manswr, B., Ball, C., Forrester, A., Chantrey, J. & Ganapathy, K. Evaluation of full S1 gene sequencing of classical and variant infectious bronchitis viruses extracted from allantoic fluid and FTA cards. Avian Pathology 47, 418-426, doi:10.1080/03079457.2018.1471196 (2018).

228    Huang, P. et al. A Rapid and Specific Assay for the Detection of MERS-CoV. Frontiers in Microbiology 9, doi:10.3389/fmicb.2018.01101 (2018).

229    Hou, P. L., Zhao, G. M., Wang, H. M., He, C. Q. & He, H. B. Rapid detection of bovine viral diarrhea virus using recombinase polymerase amplification combined with lateral flow dipstick assays in bulk milk. Veterinarski Arhiv 88, 627-642, doi:10.24099/vet.arhiv.0145 (2018).

230    Goceri, E. & Gunay, M. Automated Detection of Facial Disorders (ADFD): a novel approach based-on digital photographs. Computer Methods in Biomechanics and Biomedical Engineering-Imaging and Visualization 6, 607-617, doi:10.1080/21681163.2017.1317292 (2018).

231    Eggers, M., Koburger-Janssen, T., Eickmann, M. & Zorn, J. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infectious Diseases and Therapy 7, 249-259, doi:10.1007/s40121-018-0200-7 (2018).

232    Bonny, T. S., Yezli, S. & Lednicky, J. A. Isolation and identification of human coronavirus 229E from frequently touched environmental surfaces of a university classroom that is cleaned daily. American Journal of Infection Control 46, 105-107, doi:10.1016/j.ajic.2017.07.014 (2018).

233    Vazquez, L., Lima, L. & Almeida, M. D. Comprehensive structural analysis of designed incomplete polypeptide chains of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus. Plos One 12, doi:10.1371/journal.pone.0182132 (2017).

234    Trudeau, M. P. et al. Environmental persistence of porcine coronaviruses in feed and feed ingredients. Plos One 12, doi:10.1371/journal.pone.0178094 (2017).

235    Noi, N. V. & Chung, Y. C. Optimization of expression and purification of recombinant S1 domain of the porcine epidemic diarrhea virus spike (PEDV-S1) protein in Escherichia coli. Biotechnology & Biotechnological Equipment 31, 619-629, doi:10.1080/13102818.2017.1308231 (2017).

236    Mahendran, S. A., Booth, R. & Bell, N. J. Randomised control trial of NSAID and antimicrobial treatments for pyrexia caused by bovine respiratory disease. Cattle Practice 25, 259-266 (2017).

237    Liu, P. L. et al. Prevalence and genetic diversity analysis of human coronaviruses among cross-border children. Virology Journal 14, doi:10.1186/s12985-017-0896-0 (2017).

238    Lee, S. J. et al. Prevalence of respiratory virus infection with regard to age, sex, and seasonality factors: A single center experience against children hospitalized during the 10 years. Allergy Asthma & Respiratory Disease 5, 320-325, doi:10.4168/aard.2017.5.6.320 (2017).

239    Kang, C. K. et al. Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. Journal of Korean Medical Science 32, 744-749, doi:10.3346/jkms.2017.32.5.744 (2017).

240    Jeong, H. et al. Impact of Middle East respiratory syndrome outbreak on the use of emergency medical resources in febrile patients. Clinical and Experimental Emergency Medicine 4, 94-101, doi:10.15441/ceem.16.166 (2017).

241    Herfst, S. et al. Drivers of airborne human-to-human pathogen transmission. Current Opinion in Virology 22, 22-29, doi:10.1016/j.coviro.2016.11.006 (2017).

242    Gomez, D. E., Arroyo, L. G., Poljak, Z., Viel, L. & Weese, J. S. Detection of Bovine Coronavirus in Healthy and Diarrheic Dairy Calves. Journal of Veterinary Internal Medicine 31, 1884-1891, doi:10.1111/jvim.14811 (2017).

243    Fagbo, S. F. et al. Acute viral respiratory infections among children in MERS-endemic Riyadh, Saudi Arabia, 2012-2013. Journal of Medical Virology 89, 195-201, doi:10.1002/jmv.24632 (2017).

244    Dayer, M. R., Taleb-Gassabi, S. & Dayer, M. S. Lopinavir; A Potent Drug against Coronavirus Infection: Insight from Molecular Docking Study. Archives of Clinical Infectious Diseases 12, doi:10.5812/archcid.13823 (2017).

245    Cottingim, K. M. et al. Feed additives decrease survival of delta coronavirus in nursery pig diets. Porcine Health Management 3, doi:10.1186/s40813-016-0048-8 (2017).

246    in Fenner’s Veterinary Virology (Fifth Edition)   (eds N. James MacLachlan & Edward J. Dubovi)  435-461 (Academic Press, 2017).

247    Zeng, C. et al. Identification and Characterization of a Ribose 2 ‘-O-Methyltransferase Encoded by the Ronivirus Branch of Nidovirales. Journal of Virology 90, 6675-6685, doi:10.1128/jvi.00658-16 (2016).

248    Wansaula, Z. et al. Surveillance for severe acute respiratory infections in Southern Arizona, 2010-2014. Influenza and Other Respiratory Viruses 10, 161-169, doi:10.1111/irv.12360 (2016).

249    Wan, Z. Z. et al. A Melting Curve-Based Multiplex RT-qPCR Assay for Simultaneous Detection of Four Human Coronaviruses. International Journal of Molecular Sciences 17, doi:10.3390/ijms17111880 (2016).

250    Tun, H. M., Cai, Z. B. & Khafipour, E. Monitoring Survivability and Infectivity of Porcine Epidemic Diarrhea Virus (PEDv) in the Infected On-Farm Earthen Manure Storages (EMS). Frontiers in Microbiology 7, doi:10.3389/fmicb.2016.00265 (2016).

251    Tan, M. M. et al. Severe pneumonia due to infection with Candida krusei in a case of suspected Middle East respiratory syndrome: A case report and literature review. Experimental and Therapeutic Medicine 12, 4085-4088, doi:10.3892/etm.2016.3892 (2016).

252    Stewart, P. D. S. Seasonality and selective trends in viral acute respiratory tract infections. Medical Hypotheses 86, 104-119, doi:10.1016/j.mehy.2015.11.005 (2016).

253    Son, J. H. et al. Rapid Optical Cavity PCR. Advanced Healthcare Materials 5, 167-174, doi:10.1002/adhm.201500708 (2016).

254    Salmon-Rousseau, A., Piednoir, E., Cattoir, V. & de La Blanchardiere, A. Hajj-associated infections. Medecine Et Maladies Infectieuses 46, 346-354, doi:10.1016/j.medmal.2016.04.002 (2016).

255    Poonsuk, K. et al. Does Circulating Antibody Play a Role in the Protection of Piglets against Porcine Epidemic Diarrhea Virus? Plos One 11, doi:10.1371/journal.pone.0153041 (2016).

256    Park, G. E. et al. Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea. Annals of Internal Medicine 165, 87-+, doi:10.7326/m15-2495 (2016).

257    Otter, J. A. et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. Journal of Hospital Infection 92, 235-250, doi:10.1016/j.jhin.2015.08.027 (2016).

258    Oma, V. S., Traven, M., Alenius, S., Myrmel, M. & Stokstad, M. Bovine coronavirus in naturally and experimentally exposed calves; viral shedding and the potential for transmission. Virology Journal 13, doi:10.1186/s12985-016-0555-x (2016).

259    Moser, L. A. et al. A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA Viruses. Msystems 1, doi:10.1128/mSystems.00039-15 (2016).

260    Gurgel, R. Q. et al. Relative frequency, Possible Risk Factors, Viral Codetection Rates, and Seasonality of Respiratory Syncytial Virus Among Children With Lower Respiratory Tract Infection in Northeastern Brazil. Medicine 95, doi:10.1097/md.0000000000003090 (2016).

261    Ellis, C. et al. Detection of respiratory viruses and bacteria in children using a twenty-two target reverse-transcription real-time PCR (RT-qPCR) panel. World Journal of Pediatrics 12, 183-189, doi:10.1007/s12519-015-0069-4 (2016).

262    Cockrum, R. R. et al. Genetic parameters estimated at receiving for circulating cortisol, immunoglobulin G, interleukin 8, and incidence of bovine respiratory disease in feedlot beef steers. Journal of Animal Science 94, 2770-2778, doi:10.2527/jas.2015-0222 (2016).

263    Andrejcakova, Z. et al. Synbiotics suppress the release of lactate dehydrogenase, promote non-specific immunity and integrity of jejunum mucosa in piglets. Animal Science Journal 87, 1157-1166, doi:10.1111/asj.12558 (2016).

264    Thomas, P. R. et al. Evaluation of time and temperature sufficient to inactivate porcine epidemic diarrhea virus in swine feces on metal surfaces. Journal of Swine Health and Production 23, 84-90 (2015).

265    Sun, S. H. et al. Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys. Clinical Infectious Diseases 60, 586-595, doi:10.1093/cid/ciu887 (2015).

266    Song, D. et al. Development and Validation of a Rapid Immunochromatographic Assay for Detection of Middle East Respiratory Syndrome Coronavirus Antigen in Dromedary Camels. Journal of Clinical Microbiology 53, 1178-1182, doi:10.1128/jcm.03096-14 (2015).

267    Mielech, A. M. et al. Murine Coronavirus Ubiquitin-Like Domain Is Important for Papain-Like Protease Stability and Viral Pathogenesis. Journal of Virology 89, 4907-4917, doi:10.1128/jvi.00338-15 (2015).

268    Liu, D. F. et al. Establishment of reverse transcription loop-mediated isothermal amplification for rapid detection and differentiation of canine distemper virus infected and vaccinated animals. Infection Genetics and Evolution 32, 102-106, doi:10.1016/j.meegid.2015.03.002 (2015).

269    Lim, T. H. et al. Successful cross-protective efficacy induced by heat-adapted live attenuated nephropathogenic infectious bronchitis virus derived from a natural recombinant strain. Vaccine 33, 7370-7374, doi:10.1016/j.vaccine.2015.07.043 (2015).

270    Korzeniewski, K., Nitsch-Osuch, A., Konior, M. & Lass, A. Respiratory tract infections in the military environment. Respiratory Physiology & Neurobiology 209, 76-80, doi:10.1016/j.resp.2014.09.016 (2015).

271    Kim, Y. K. et al. A novel diagnostic approach to detecting porcine epidemic diarrhea virus: The lateral immunochromatography assay. Journal of Virological Methods 225, 4-8, doi:10.1016/j.jviromet.2015.08.024 (2015).

272    Johnson, A. L., McAdams-Gallagher, S. C. & Aceto, H. Outcome of Adult Horses with Botulism Treated at a Veterinary Hospital: 92 Cases (1989-2013). Journal of Veterinary Internal Medicine 29, 311-319, doi:10.1111/jvim.12502 (2015).

273    Du, Y. et al. A Sweet Spot for Molecular Diagnostics: Coupling Isothermal Amplification and Strand Exchange Circuits to Glucometers. Scientific Reports 5, doi:10.1038/srep11039 (2015).

274    Cui, B. L. et al. Viral aetiology of acute respiratory infections among children and associated meteorological factors in southern China. Bmc Infectious Diseases 15, doi:10.1186/s12879-015-0863-6 (2015).

275    Chen, H. X. et al. Development and Evaluation of a SYBR Green-Based Real-Time Multiplex RT-PCR Assay for Simultaneous Detection and Serotyping of Dengue and Chikungunya Viruses. Journal of Molecular Diagnostics 17, 722-728, doi:10.1016/j.jmoldx.2015.06.008 (2015).

276    Casanova, L. M. & Weaver, S. R. Inactivation of an Enveloped Surrogate Virus in Human Sewage. Environmental Science & Technology Letters 2, 76-78, doi:10.1021/acs.estlett.5b00029 (2015).

277    Arvia, R., Corcioli, F., Ciccone, N., Della Malva, N. & Azzi, A. Detection of 12 respiratory viruses by duplex real time PCR assays in respiratory samples. Molecular and Cellular Probes 29, 408-413, doi:10.1016/j.mcp.2015.08.006 (2015).

278    Weiss, K. A., Knudson, C. J., Christiaansen, A. F. & Varga, S. M. Animal Models of Human Respiratory Viral Infections.  (2014).

279    Siu, K.-L., Chan, C.-P., Kok, K.-H., Chiu-Yat Woo, P. & Jin, D.-Y. Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain. Cellular & Molecular Immunology 11, 141-149, doi:10.1038/cmi.2013.61 (2014).

280    Shirato, K. et al. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virology Journal 11, doi:10.1186/1743-422x-11-139 (2014).

281    Ramos-Vara, J. A., Webster, J. D., DuSold, D. & Miller, M. A. Immunohistochemical Evaluation of the Effects of Paraffin Section Storage on Biomarker Stability. Veterinary Pathology 51, 102-109, doi:10.1177/0300985813476067 (2014).

282    Pujols, J. & Segales, J. Survivability of porcine epidemic diarrhea virus (PEDV) in bovine plasma submitted to spray drying processing and held at different time by temperature storage conditions. Veterinary Microbiology 174, 427-432, doi:10.1016/j.vetmic.2014.10.021 (2014).

283    O’Shea, T. J. et al. Bat Flight and Zoonotic Viruses. Emerging Infectious Diseases 20, 741-745, doi:10.3201/eid2005.130539 (2014).

284    Meng, F. D. et al. A phage-displayed peptide recognizing porcine aminopeptidase N is a potent small molecule inhibitor of PEDV entry. Virology 456, 20-27, doi:10.1016/j.virol.2014.01.010 (2014).

285    Love, W. J., Lehenbauer, T., Kass, P. H., Van Eenennaam, A. L. & Aly, S. S. Development of a novel clinical scoring systemfor on-farmdiagnosis of bovine respiratory disease in pre-weaned dairy calves. Peerj 2, doi:10.7717/peerj.238 (2014).

286    Liang, X., Chigerwe, M., Hietala, S. K. & Crossley, B. M. Evaluation of Fast Technology Analysis (FTA) Cards as an improved method for specimen collection and shipment targeting viruses associated with Bovine Respiratory Disease Complex. Journal of Virological Methods 202, 69-72, doi:10.1016/j.jviromet.2014.02.022 (2014).

287    Leclercq, I., Batejat, C., Burguiere, A. M. & Manuguerra, J. C. Heat inactivation of the Middle East respiratory syndrome coronavirus. Influenza and Other Respiratory Viruses 8, 585-586, doi:10.1111/irv.12261 (2014).

288    Huang, S. W. et al. The genotyping of Infectious bronchitis virus in Taiwan by a multiplex amplification refractory mutation system reverse transcription polymerase chain reaction. Journal of Veterinary Diagnostic Investigation 26, 721-733, doi:10.1177/1040638714547735 (2014).

289    Florek, D., Burmistrz, M., Potempa, J. & Pyrc, K. Stability of infectious human coronavirus NL63. Journal of Virological Methods 205, 87-90, doi:10.1016/j.jviromet.2014.04.001 (2014).

290    Chang, L. Y. et al. Viral infections associated with Kawasaki disease. Journal of the Formosan Medical Association 113, 148-154, doi:10.1016/j.jfma.2013.12.008 (2014).

291    Aydin, H., Al-Khooly, D. & Lee, J. E. Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: Insights into mechanisms of general viral fusion and inhibitor design. Protein Science 23, 603-617, doi:10.1002/pro.2442 (2014).

292    Al-Mulla, H. M. N. et al. Competitive Fitness in Coronaviruses Is Not Correlated with Size or Number of Double-Membrane Vesicles under Reduced-Temperature Growth Conditions. Mbio 5, doi:10.1128/mBio.01107-13 (2014).

293    Yin, J. K. et al. Estimates and determinants of economic impacts from influenza-like illnesses caused by respiratory viruses in Australian children attending childcare: a cohort study. Influenza and Other Respiratory Viruses 7, 1103-1112, doi:10.1111/irv.12138 (2013).

294    van Doremalen, N., Bushmaker, T. & Munster, V. J. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Eurosurveillance 18, 7-10, doi:10.2807/1560-7917.es2013.18.38.20590 (2013).

295    Tapparel, C. et al. Growth and characterization of different human rhinovirus C types in three-dimensional human airway epithelia reconstituted in vitro. Virology 446, 1-8, doi:10.1016/j.virol.2013.06.031 (2013).

296    Stobart, C. C. et al. Chimeric Exchange of Coronavirus nsp5 Proteases (3CLpro) Identifies Common and Divergent Regulatory Determinants of Protease Activity. Journal of Virology 87, 12611-12618, doi:10.1128/jvi.02050-13 (2013).

297    Litster, A. L., Pogranichniy, R. & Lin, T. L. Diagnostic utility of a direct immunofluorescence test to detect feline coronavirus antigen in macrophages in effusive feline infectious peritonitis. Veterinary Journal 198, 362-366, doi:10.1016/j.tvjl.2013.08.023 (2013).

298    Ishimaru, D. et al. RNA dimerization plays a role in ribosomal frameshifting of the SARS coronavirus. Nucleic Acids Research 41, 2594-2608, doi:10.1093/nar/gks1361 (2013).

299    Guionie, O. et al. An experimental study of the survival of turkey coronavirus at room temperature and+4 degrees C. Avian Pathology 42, 248-252, doi:10.1080/03079457.2013.779364 (2013).

300    Beachboard, D. C., Lu, X. T., Baker, S. C. & Denison, M. R. Murine hepatitis virus nsp4 N258T mutants are not temperature-sensitive. Virology 435, 210-213, doi:10.1016/j.virol.2012.10.001 (2013).

301    Stobart, C. C., Lee, A. S., Lu, X. T. & Denison, M. R. Temperature-Sensitive Mutants and Revertants in the Coronavirus Nonstructural Protein 5 Protease (3CLpro) Define Residues Involved in Long-Distance Communication and Regulation of Protease Activity. Journal of Virology 86, 4801-4810, doi:10.1128/jvi.06754-11 (2012).

302    Mullis, L., Saif, L. J., Zhang, Y. B., Zhang, X. M. & Azevedo, M. S. P. Stability of bovine coronavirus on lettuce surfaces under household refrigeration conditions. Food Microbiology 30, 180-186, doi:10.1016/j.fm.2011.12.009 (2012).

303    Geller, C., Varbanov, M. & Duval, R. E. Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies. Viruses-Basel 4, 3044-3068, doi:10.3390/v4113044 (2012).

304    Dijkman, R. et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. Journal of General Virology 93, 1924-1929, doi:10.1099/vir.0.043919-0 (2012).

305    Chen, K. Y. et al. Development and evaluation of an immunochromatographic strip for rapid detection of porcine hemagglutinating encephalomyelitis virus. Virology Journal 9, doi:10.1186/1743-422x-9-172 (2012).

306    Razanajatovo, N. H. et al. Viral Etiology of Influenza-Like Illnesses in Antananarivo, Madagascar, July 2008 to June 2009. Plos One 6, doi:10.1371/journal.pone.0017579 (2011).

307    Luinstra, K. et al. Evaluation and Clinical Validation of an Alcohol-Based Transport Medium for Preservation and Inactivation of Respiratory Viruses. Journal of Clinical Microbiology 49, 2138-2142, doi:10.1128/jcm.00327-11 (2011).

308    Emmoth, E., Ottoson, J., Albihn, A., Belak, S. & Vinneras, B. Ammonia Disinfection of Hatchery Waste for Elimination of Single-Stranded RNA Viruses. Applied and Environmental Microbiology 77, 3960-3966, doi:10.1128/aem.02990-10 (2011).

309    Chen, K. Y. et al. Development of an immunochromatographic strip for serological diagnosis of Porcine hemagglutinating encephalomyelitis virus. Journal of Veterinary Diagnostic Investigation 23, 288-296, doi:10.1177/104063871102300214 (2011).

310    Chen, C. C. et al. ORF8a of SARS-CoV forms an ion channel: Experiments and molecular dynamics simulations. Biochimica Et Biophysica Acta-Biomembranes 1808, 572-579, doi:10.1016/j.bbamem.2010.08.004 (2011).

311    Chang, G. H. et al. Genetic analysis of murine hepatitis virus non-structural protein 16. Journal of General Virology 92, 122-127, doi:10.1099/vir.0.026781-0 (2011).

312    Zhang, C. F., Cui, S. J. & Zhu, C. Loop-mediated isothermal amplification for rapid detection and differentiation of wild-type pseudorabies and gene-deleted virus vaccines. Journal of Virological Methods 169, 239-243, doi:10.1016/j.jviromet.2010.07.034 (2010).

313    Thaitrong, N. et al. Integrated Capillary Electrophoresis Microsystem for Multiplex Analysis of Human Respiratory Viruses. Analytical Chemistry 82, 10102-10109, doi:10.1021/ac1020744 (2010).

314    Sundararajan, A. et al. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Research 88, 1-9, doi:10.1016/j.antiviral.2010.06.014 (2010).

315    Stokes, H. L. et al. A New Cistron in the Murine Hepatitis Virus Replicase Gene. Journal of Virology 84, 10148-10158, doi:10.1128/jvi.00901-10 (2010).

316    Raaben, M. et al. The Ubiquitin-Proteasome System Plays an Important Role during Various Stages of the Coronavirus Infection Cycle. Journal of Virology 84, 7869-7879, doi:10.1128/jvi.00485-10 (2010).

317    Casanova, L. M., Jeon, S., Rutala, W. A., Weber, D. J. & Sobsey, M. D. Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces. Applied and Environmental Microbiology 76, 2712-2717, doi:10.1128/aem.02291-09 (2010).

318    Zvizdic, S. et al. Etiologic-epidemiologic characteristics of acute diarrheal diseases in pre-school children. Healthmed 3, 244-253 (2009).

319    Woo, P. C. Y. et al. The Complete Genome and Proteome of Laribacter hongkongensis Reveal Potential Mechanisms for Adaptations to Different Temperatures and Habitats. Plos Genetics 5, doi:10.1371/journal.pgen.1000416 (2009).

320    Sung, R. Y. T. et al. Identification of Viral and Atypical Bacterial Pathogens in Children Hospitalized With Acute Respiratory Infections in Hong Kong by Multiplex PCR Assays. Journal of Medical Virology 81, 153-159, doi:10.1002/jmv.21364 (2009).

321    Gundy, P. M., Gerba, C. P. & Pepper, I. L. Survival of Coronaviruses in Water and Wastewater. Food and Environmental Virology 1, 10-14, doi:10.1007/s12560-008-9001-6 (2009).

322    Fang, H. J. et al. Thermostability of the N-Terminal RNA-Binding Domain of the SARS-CoV Nucleocapsid Protein: Experiments and Numerical Simulations. Biophysical Journal 96, 1892-1901, doi:10.1016/j.bpj.2008.10.045 (2009).

323    da Silva, S. E. L. et al. EPIDEMIOLOGICAL ASPECTS OF ASTROVIRUS AND CORONAVIRUS IN POULTS IN THE SOUTH EASTERN REGION OF BRAZIL. Brazilian Journal of Microbiology 40, 248-253, doi:10.1590/s1517-83822009000200008 (2009).

324    Chen, P., Hu, T., Jiang, M. & Guo, D. Synthesis in Escherichia coli cells and characterization of the active exoribonuclease of severe acute respiratory syndrome coronavirus. Molecular Biology 43, 410-417, doi:10.1134/s0026893309030091 (2009).

325    Berge, A. C. B., Besser, T. E., Moore, D. A. & Sischo, W. M. Evaluation of the effects of oral colostrum supplementation during the first fourteen days on the health and performance of preweaned calves. Journal of Dairy Science 92, 286-295, doi:10.3168/jds.2008-1433 (2009).

326    Basu, D. et al. Novel Influenza Virus NS1 Antagonists Block Replication and Restore Innate Immune Function. Journal of Virology 83, 1881-1891, doi:10.1128/jvi.01805-08 (2009).

327    Zhong, N. et al. Without its N-finger, the main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain. Journal of Virology 82, 4227-4234, doi:10.1128/jvi.02612-07 (2008).

328    Yang, Y. L., Wang, Q. & Guo, D. Y. A novel strategy for analyzing RNA-protein interactions by surface plasmon resonance biosensor. Molecular Biotechnology 40, 87-93, doi:10.1007/s12033-008-9066-3 (2008).

329    Sparks, J. S., Donaldson, E. F., Lu, X. T., Baric, R. S. & Denison, M. R. A novel mutation in murine hepatitis virus nsp5, the viral 3C-like proteinase, causes temperature-sensitive defects in viral growth and protein processing. Journal of Virology 82, 5999-6008, doi:10.1128/jvi.00203-08 (2008).

330    Pratelli, A. Canine coronavirus inactivation with physical and chemical agents. Veterinary Journal 177, 71-79, doi:10.1016/j.tvjl.2007.03.019 (2008).

331    He, J. H. Fatalness of virus depends upon its cell fractal geometry. Chaos Solitons & Fractals 38, 1390-1393, doi:10.1016/j.chaos.2008.04.018 (2008).

332    Graham, R. L., Sparks, J. S., Eckerle, L. D., Sims, A. C. & Denison, M. R. SARS coronavirus replicase proteins in pathogenesis. Virus Research 133, 88-100, doi:10.1016/j.virusres.2007.02.017 (2008).

333    Decaro, N. et al. Severe outbreak of bovine coronavirus infection in dairy cattle during the warmer season. Veterinary Microbiology 126, 30-39, doi:10.1016/j.vetmic.2007.06.024 (2008).

334    Clementz, M. A., Kanjanahaluethai, A., O’Brien, T. E. & Baker, S. C. Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles. Virology 375, 118-129, doi:10.1016/j.virol.2008.01.018 (2008).

335    Chu, Y. K. et al. The SARS-CoV ferret model in an infection-challenge study. Virology 374, 151-163, doi:10.1016/j.virol.2007.12.032 (2008).

336    Chiang, M. F. et al. Mass Screening of Suspected Febrile Patients with Remote-sensing Infrared Thermography: Alarm Temperature and Optimal Distance. Journal of the Formosan Medical Association 107, 937-944, doi:10.1016/s0929-6646(09)60017-6 (2008).

337    Versteeg, G. A., van de Nes, P. S., Bredenbeek, P. J. & Spaan, W. J. M. The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations. Journal of Virology 81, 10981-10990, doi:10.1128/jvi.01033-07 (2007).

338    Sanavio, B., Piccoli, A., Gianni, T. & Bertucci, C. Helicity propensity and interaction of synthetic peptides from heptad-repeat domains of herpes simplex virus 1 glycoprotein H: A circular dichroism study. Biochimica Et Biophysica Acta-Proteins and Proteomics 1774, 781-791, doi:10.1016/j.bbapap.2007.04.019 (2007).

339    Liu, W. Z. et al. Helicobacter pylori acyl carrier protein: Expression, purification, and its interaction with beta-hydroxyacyl-ACP dehydratase. Protein Expression and Purification 52, 74-81, doi:10.1016/j.pep.2006.09.003 (2007).

340    Fu, Y. J. et al. Supercritical fluid extraction of seed oil from chinese licorice Glycyrrhiza uralensis Fisch.): Chemical composition and antibacterial activity. South African Journal of Chemistry-Suid-Afrikaanse Tydskrif Vir Chemie 60, 67-70 (2007).

341    Donaldson, E. F., Graham, R. L., Sims, A. C., Denison, M. R. & Baric, R. S. Analysis of murine hepatitis virus mutant TS-LA6 suggests that polyprotein vol. 81, no. 13 strain A59 temperature-sensitive nsp10 plays a critical role in processing. Journal of Virology 81, 7086-7098, doi:10.1128/jvi.00049-07 (2007).

342    DeDiego, M. L. et al. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. Journal of Virology 81, 1701-1713, doi:10.1128/jvi.01467-06 (2007).

343    Cann, S. A. H. Febrile seizures in young children: Role of fluid intake and conservation. Medical Science Monitor 13, RA159-RA167 (2007).

344    Cai, Q. C. et al. Influence of meteorological factors and air pollution on the outbreak of severe acute respiratory syndrome. Public Health 121, 258-265, doi:10.1016/j.puhe.2006.09.023 (2007).

345    Zheng, Q. et al. Core structure of S2 from the human coronavirus NL63 spike Glycoprotein. Biochemistry 45, 15205-15215, doi:10.1021/bi061686w (2006).

346    Yuan, J. S. et al. A climatologic investigation of the SARS-CoV outbreak in Beijing, China. American Journal of Infection Control 34, 234-236, doi:10.1016/j.ajic.2005.12.006 (2006).

347    Yu, C. M. et al. Cardiovascular complications of severe acute respiratory syndrome. Postgraduate Medical Journal 82, 140-144, doi:10.1136/pgmj.2005.037515 (2006).

348    Muller, M. P. et al. Early diagnosis of SARS: lessons from the Toronto SARS outbreak. European Journal of Clinical Microbiology & Infectious Diseases 25, 230-237, doi:10.1007/s10096-006-0127-x (2006).

349    Masters, P. S. in Advances in Virus Research, Vol 66 Vol. 66 Advances in Virus Research (eds K. Maramorosch & A. J. Shatkin)  193-292 (2006).

350    Lin, K., Fong, D. Y. K., Zhu, B. L. & Karlberg, J. Environmental factors on the SARS epidemic: air temperature, passage of time and multiplicative effect of hospital infection. Epidemiology and Infection 134, 223-230, doi:10.1017/s0950268805005054 (2006).

351    Leong, H. N. et al. SARS in Singapore – Predictors of disease severity. Annals Academy of Medicine Singapore 35, 326-331 (2006).

352    Lau, S. K. P. et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. Journal of Clinical Microbiology 44, 2063-2071, doi:10.1128/jcm.02614-05 (2006).

353    Ho, H. T. et al. Colonization of severe acute respiratory syndrome-associated coronavirus among health-care workers screened by nasopharyngeal swab. Chest 129, 95-101, doi:10.1378/chest.129.1.95 (2006).

354    Chu, V. C., McElroy, L. J., Chu, V., Bauman, B. E. & Whittaker, G. R. The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells. Journal of Virology 80, 3180-3188, doi:10.1128/jvi.80.7.3180-3188.2006 (2006).

355    Yu, C. Y. et al. Folding of the SARS coronavirus spike glycoprotein immunological fragment (SARS-S1B): Thermodynamic and kinetic investigation correlating with three-dimensional structural modeling. Biochemistry 44, 1453-1463, doi:10.1021/bi0482396 (2005).

356    Tan, J. G. et al. An initial investigation of the association between the SARS outbreak and weather: with the view of the environmental temperature and its variation. Journal of Epidemiology and Community Health 59, 186-192, doi:10.1136/jech.2004.020180 (2005).

357    Sawicki, S. G. et al. Functional and genetic analysis of coronavirus replicase-transcriptase proteins. Plos Pathogens 1, 310-322, doi:10.1371/journal.ppat.0010039 (2005).

358    Ng, E. Y. K., Chong, C. & Kaw, G. J. L. CLASSIFICATION OF HUMAN FACIAL AND AURAL TEMPERATURE USING NEURAL NETWORKS AND IR FEVER SCANNER: A RESPONSIBLE SECOND LOOK. Journal of Mechanics in Medicine and Biology 5, 165-190, doi:10.1142/s0219519405001370 (2005).

359    Ng, E. Y. K. Is thermal scanner losing its bite in mass screening of fever due to SARS? Medical Physics 32, 93-97, doi:10.1118/1.1819532 (2005).

360    Lai, M. Y. Y., Cheng, P. K. C. & Lim, W. W. L. Survival of severe acute respiratory syndrome coronavirus. Clinical Infectious Diseases 41, E67-E71, doi:10.1086/433186 (2005).

361    Chiu, S. S. et al. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clinical Infectious Diseases 40, 1721-1729, doi:10.1086/430301 (2005).

362    Chen, S. et al. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique. Acta Pharmacologica Sinica 26, 99-106, doi:10.1111/j.1745-7254.2005.00010.x (2005).

363    Wu, W. et al. Comparison of clinical course of patients with severe acute respiratory syndrome among the multiple generations of nosocomial transmission. Chinese Medical Journal 117, 14-18 (2004).

364    So, R. C. H., Ko, J., Yuan, Y. W. Y., Lam, J. J. & Louie, L. Severe Acute Respiratory Syndrome and sport – Facts and fallacies. Sports Medicine 34, 1023-1033, doi:10.2165/00007256-200434150-00002 (2004).

365    Shen, S., Law, Y. C. & Liu, D. X. A single amino acid mutation in the spike protein of coronavirus infectious bronchitis virus hampers its maturation and incorporation into virions at the nonpermissive temperature. Virology 326, 288-298, doi:10.1016/j.virol.2004.06.016 (2004).

366    Nomura, R. et al. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. Journal of Virology 78, 8701-8708, doi:10.1128/jvi.78.16.8701-8708.2004 (2004).

367    Liu, J. A rate equation approach to model the denaturation or replication behavior of the SARS coronavirus. Forschung Im Ingenieurwesen-Engineering Research 68, 227-238, doi:10.1007/s10010-004-0130-2 (2004).

368    Lin, C. L. et al. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest 126, 509-517, doi:10.1378/chest.126.2.509 (2004).

369    He, H. et al. Catalytic inactivation of SARS coronavirus, Escherichia coli and yeast on solid surface. Catalysis Communications 5, 170-172, doi:10.1016/j.catcom.2003.12.009 (2004).

370    Fung, C. P. et al. Rapid creation of a temporary isolation ward for patients with severe acute respiratory syndrome in Taiwan. Infection Control and Hospital Epidemiology 25, 1026-1032, doi:10.1086/502339 (2004).

371    Emery, S. L. et al. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 10, 311-316, doi:10.3201/eid1002.030759 (2004).

372    Chen, S. Y. et al. Sequential symptomatic analysis in probable severe acute respiratory syndrome cases. Annals of Emergency Medicine 43, 27-33, doi:10.1016/j.annemergmed.2003.10.010 (2004).

373    Babyn, P. S. et al. Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatric Radiology 34, 47-58, doi:10.1007/s00247-003-1081-8 (2004).

374    Andrews, A. H. Colostrum – Not just for 24 hours. Cattle Practice 12, 121-124 (2004).

375    Zelus, B. D., Schickli, J. H., Blau, D. M., Weiss, S. R. & Holmes, K. V. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. Journal of Virology 77, 830-840, doi:10.1128/jvi.77.2.830-840.2003 (2003).

376    Wu, W. et al. A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China. Chinese Medical Journal 116, 811-818 (2003).

377    Stadler, K. et al. SARS – Beginning to understand a new virus. Nature Reviews Microbiology 1, 209-218, doi:10.1038/nrmicro775 (2003).

378    Duan, S. M. et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomedical and Environmental Sciences 16, 246-255 (2003).

379    Ortego, J., Escors, D., Laude, H. & Enjuanes, L. Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. Journal of Virology 76, 11518-11529, doi:10.1128/jvi.76.22.11518-11529.2002 (2002).

380    Matthews, A. E., Weiss, S. R. & Paterson, Y. Murine hepatitis virus – A model for virus-induced CNS demyelination. Journal of Neurovirology 8, 76-85, doi:10.1080/13550280290049534 (2002).

381    Matsuyama, S. & Taguchi, F. Receptor-induced conformational changes of murine coronavirus spike protein. Journal of Virology 76, 11819-11826, doi:10.1128/jvi.76.23.11819-11826.2002 (2002).

382    Kadoi, K., Sugioka, H., Satoh, T. & Kadoi, B. K. The propagation of a porcine epidemic diarrhea virus in swine cell lines. Microbiologica 25, 285-290 (2002).

383    Grandemange, E., Mathevet, P., Charrier, E. & Davot, J. L. Use of marbofloxacin to treat K99 Escherichia coli gastroenteritis in newborn calves. Irish Veterinary Journal 55, 180-+ (2002).

384    Arthington, J. D., Jaynes, C. A., Tyler, H. D., Kapil, S. & Quigley, J. D. The use of bovine serum protein as an oral support therapy following coronavirus challenge in calves. Journal of Dairy Science 85, 1249-1254, doi:10.3168/jds.S0022-0302(02)74189-1 (2002).

385    Van Reeth, K., Nauwynck, H. & Pensaert, M. Clinical effects of experimental dual infections with porcine reproductive and respiratory syndrome virus followed by swine influenza virus in conventional and colostrum-deprived pigs. Journal of Veterinary Medicine Series B-Infectious Diseases and Veterinary Public Health 48, 283-292, doi:10.1046/j.1439-0450.2001.00438.x (2001).

386    Shen, S. & Liu, D. X. in Nidoviruses Vol. 494 Advances in Experimental Medicine and Biology (eds E. Lavi, S. R. Weiss, & S. T. Hingley)  557-562 (2001).

387    Holmes, K. V. in Gastroenteritis Viruses Vol. 238 Novartis Foundation Symposium (eds D. Chadwick & J. A. Goode)  258-275 (2001).

388    Cho, K. O. et al. Cross-protection studies between respiratory and calf diarrhea and winter dysentery coronavirus strains in calves and RT-PCR and nested PCR for their detection. Archives of Virology 146, 2401-2419, doi:10.1007/s007050170011 (2001).

389    Shibata, I. et al. Isolation of porcine epidemic diarrhea virus in porcine cell cultures and experimental infection of pigs of different ages. Veterinary Microbiology 72, 173-182, doi:10.1016/s0378-1135(99)00199-6 (2000).

390    Naslund, K., Traven, M., Larsson, B., Silvan, A. & Linde, N. Capture ELISA systems for the detection of bovine coronavirus-specific IgA and IgM antibodies in milk and serum. Veterinary Microbiology 72, 183-206, doi:10.1016/s0378-1135(99)00208-4 (2000).

391    Lin, X. Q., Chouljenko, V. N., Kousoulas, K. G. & Storz, J. Temperature-sensitive acetylesterase activity of haemagglutinin-esterase specified by respiratory bovine coronaviruses. Journal of Medical Microbiology 49, 1119-1127, doi:10.1099/0022-1317-49-12-1119 (2000).

392    Cho, K. O. et al. Detection and isolation of coronavirus from feces of three herds of feedlot cattle during outbreaks of winter dysentery-like disease. Journal of the American Veterinary Medical Association 217, 1191-+, doi:10.2460/javma.2000.217.1191 (2000).

393    Zakhartchouk, A. N. et al. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. Journal of General Virology 80, 1263-1269, doi:10.1099/0022-1317-80-5-1263 (1999).

394    van der Meer, Y. et al. Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. Journal of Virology 73, 7641-7657, doi:10.1128/jvi.73.9.7641-7657.1999 (1999).

395    Teng, H., Pinon, J. D. & Weiss, S. R. Expression of murine coronavirus recombinant papain-like proteinase: Efficient cleavage is dependent on the lengths of both the substrate and the proteinase polypeptides. Journal of Virology 73, 2658-2666, doi:10.1128/jvi.73.4.2658-2666.1999 (1999).

396    Schoenike, B., Franta, A. K. & Fleming, J. O. Quantitative sense-specific determination of murine coronavirus RNA by reverse transcription polymerase chain reaction. Journal of Virological Methods 78, 35-49, doi:10.1016/s0166-0934(98)00167-0 (1999).

397    Walker, P. G. et al. A reliable, practical, and economical protocol for inducing diarrhea and severe dehydration in the neonatal calf. Canadian Journal of Veterinary Research-Revue Canadienne De Recherche Veterinaire 62, 205-213 (1998).

398    Stalcup, R. P., Baric, R. S. & Leibowitz, J. L. Genetic complementation among three panels of mouse hepatitis virus gene 1 mutants. Virology 241, 112-121, doi:10.1006/viro.1997.8957 (1998).

399    Rossen, J. W. A. et al. The viral spike protein is not involved in the polarized sorting of coronaviruses in epithelial cells. Journal of Virology 72, 497-503, doi:10.1128/jvi.72.1.497-503.1998 (1998).

400    Rao, P. V. & Gallagher, T. M. Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections. Journal of Virology 72, 3278-3288, doi:10.1128/jvi.72.4.3278-3288.1998 (1998).

401    Leparc-Goffart, I. et al. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. Journal of Virology 72, 9628-9636, doi:10.1128/jvi.72.12.9628-9636.1998 (1998).

402    Fischer, F., Stegen, C. F., Masters, P. S. & Samsonoff, W. A. Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly. Journal of Virology 72, 7885-7894, doi:10.1128/jvi.72.10.7885-7894.1998 (1998).

403    Zhang, L. N., Homberger, F., Spaan, W. & Luytjes, W. Recombinant genomic RNA of coronavirus MHV-A59 after coreplication with a DI RNA containing the MHV-RI spike gene. Virology 230, 93-102, doi:10.1006/viro.1997.8460 (1997).

404    Sirinarumitr, T., Paul, P. S., Halbur, P. G. & Kluge, J. P. Rapid in situ hybridization technique for the detection of ribonucleic acids in tissues using radiolabelled and flourescein-labelled riboprobes. Molecular and Cellular Probes 11, 273-280, doi:10.1006/mcpr.1997.0114 (1997).

405    Luytjes, W., Gerritsma, H., Bos, E. & Spaan, W. Characterization of two temperature-sensitive mutants of coronavirus mouse hepatitis virus strain A59 with maturation defects in the spike protein. Journal of Virology 71, 949-955, doi:10.1128/jvi.71.2.949-955.1997 (1997).

406    Lai, M. M. C. & Cavanagh, D. The molecular biology of coronaviruses. Advances in Virus Research, Vol 48 48, 1-100, doi:10.1016/s0065-3527(08)60286-9 (1997).

407    Kim, K. M. H., Narayanan, K. & Makino, S. Assembled coronavirus from complementation of two defective interfering RNAs. Journal of Virology 71, 3922-3931, doi:10.1128/jvi.71.5.3922-3931.1997 (1997).

408    Ballesteros, M. L., Sanchez, C. M. & Enjuanes, L. Two amino acid changes at the N-terminus of transmissible gastroenteritis coronavirus spike protein result in the loss of enteric tropism. Virology 227, 378-388, doi:10.1006/viro.1996.8344 (1997).

409    Baldwin, C. W. & Scott, F. W. Attempted immunization of cats with feline infectious peritonitis virus propagated at reduced temperatures. American Journal of Veterinary Research 58, 251-256 (1997).

410    Houtman, J. J. & Fleming, J. O. Pathogenesis of mouse hepatitis virus-induced demyelination. Journal of Neurovirology 2, 361-376, doi:10.3109/13550289609146902 (1996).

411    Gallagher, T. M. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. Journal of Virology 70, 4683-4690, doi:10.1128/jvi.70.7.4683-4690.1996 (1996).

412    Ricard, C. S., Koetzner, C. A., Sturman, L. S. & Masters, P. S. A conditional-lethal murine coronavirus mutant that fails to incorporate the spike glycoprotein into assembled virions. Virus Research 39, 261-276, doi:10.1016/0168-1702(95)00100-x (1995).

413    Reeves, N. P. VACCINATION AGAINST NATURALLY-OCCURRING FIP IN A SINGLE LARGE CAT SHELTER. Feline Practice 23, 81-82 (1995).

414    Peng, D., Koetzner, C. A. & Masters, P. S. ANALYSIS OF 2ND-SITE REVERTANTS OF A MURINE CORONAVIRUS NUCLEOCAPSID PROTEIN DELETION MUTANT AND CONSTRUCTION OF NUCLEOCAPSID PROTEIN MUTANTS BY TARGETED RNA RECOMBINATION. Journal of Virology 69, 3449-3457, doi:10.1128/jvi.69.6.3449-3457.1995 (1995).

415    Kim, Y. N. & Makino, S. CHARACTERIZATION OF A MURINE CORONAVIRUS DEFECTIVE INTERFERING RNA INTERNAL CIS-ACTING REPLICATION SIGNAL. Journal of Virology 69, 4963-4971, doi:10.1128/jvi.69.8.4963-4971.1995 (1995).

416    Kim, K. H. & Makino, S. 2 MURINE CORONAVIRUS GENES SUFFICE FOR VIRAL-RNA SYNTHESIS. Journal of Virology 69, 2313-2321, doi:10.1128/jvi.69.4.2313-2321.1995 (1995).

417    Hoskins, J. D., Taylor, H. W. & Lomax, T. L. INDEPENDENT EVALUATION OF A MODIFIED-LIVE FELINE INFECTIOUS PERITONITIS VIRUS-VACCINE UNDER EXPERIMENTAL CONDITIONS (LOUISIANA EXPERIENCE). Feline Practice 23, 72-73 (1995).

418    Gerber, J. D. OVERVIEW OF THE DEVELOPMENT OF A MODIFIED-LIVE TEMPERATURE-SENSITIVE FIP VIRUS-VACCINE. Feline Practice 23, 62-66 (1995).

419    Correale, J., Li, S., Weiner, L. P. & Gilmore, W. EFFECT OF PERSISTENT MOUSE HEPATITIS-VIRUS INFECTION ON MHC CLASS-I EXPRESSION IN MURINE ASTROCYTES. Journal of Neuroscience Research 40, 10-21, doi:10.1002/jnr.490400103 (1995).

420    Cavanagh, D. et al. MOLECULAR APPROACHES TO THE DIAGNOSIS AND PROPHYLAXIS OF AVIAN DISEASES. Asia-Pacific Journal of Molecular Biology and Biotechnology 3, 272-279 (1995).

421    Weiss, S. R. et al. CORONAVIRUS POLYPROTEIN PROCESSING. Archives of Virology, 349-358 (1994).

422    Tennant, B. J., Gaskell, R. M. & Gaskell, C. J. STUDIES ON THE SURVIVAL OF CANINE CORONAVIRUS UNDER DIFFERENT ENVIRONMENTAL-CONDITIONS. Veterinary Microbiology 42, 255-259, doi:10.1016/0378-1135(94)90024-8 (1994).

423    Schaad, M. C. & Baric, R. S. GENETICS OF MOUSE HEPATITIS-VIRUS TRANSCRIPTION – EVIDENCE THAT SUBGENOMIC NEGATIVE STRANDS ARE FUNCTIONAL TEMPLATES. Journal of Virology 68, 8169-8179, doi:10.1128/jvi.68.12.8169-8179.1994 (1994).

424    Masters, P. S., Koetzner, C. A., Kerr, C. A. & Heo, Y. OPTIMIZATION OF TARGETED RNA RECOMBINATION AND MAPPING OF A NOVEL NUCLEOCAPSID GENE MUTATION IN THE CORONAVIRUS MOUSE HEPATITIS-VIRUS. Journal of Virology 68, 328-337, doi:10.1128/jvi.68.1.328-337.1994 (1994).

425    Li, X. T. & Scott, F. W. DETECTION OF FELINE CORONAVIRUSES IN CELL-CULTURES AND IN FRESH AND FIXED FELINE TISSUES USING POLYMERASE CHAIN-REACTION. Veterinary Microbiology 42, 65-77, doi:10.1016/0378-1135(94)90078-7 (1994).

426    Gilmore, W., Correale, J. & Weiner, L. P. CORONAVIRUS INDUCTION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX EXPRESSION IN MURINE ASTROCYTES IS VIRUS-STRAIN SPECIFIC. Journal of Experimental Medicine 180, 1013-1023, doi:10.1084/jem.180.3.1013 (1994).

427    Fu, K. S. & Baric, R. S. MAP LOCATIONS OF MOUSE HEPATITIS-VIRUS TEMPERATURE-SENSITIVE MUTANTS – CONFIRMATION OF VARIABLE RATES OF RECOMBINATION. Journal of Virology 68, 7458-7466, doi:10.1128/jvi.68.11.7458-7466.1994 (1994).

428    Degroot, R., Heijnen, L., Vandermost, R. & Spaan, W. HOMOLOGOUS RNA RECOMBINATION ALLOWS EFFICIENT INTRODUCTION OF SITE-SPECIFIC MUTATIONS INTO THE GENOME OF CORONAVIRUS MHV-A59 VIA SYNTHETIC CO-REPLICATING RNAS. Archives of Virology, 221-230 (1994).

429    Suter, P. F., Rohrer, C. & Lutz, H. THE PROBLEMATIC NATURE OF FIP-VIRUS INFECTION. Kleintierpraxis 38, 373-378 (1993).

430    Hughes, S. A. et al. in Coronaviruses: Molecular Biology and Virus-Host Interactions Vol. 342 Advances in Experimental Medicine and Biology (eds H. Laude & J. F. Vautherot)  221-226 (1993).

431    Hohdatsu, T., Yamada, H., Ishizuka, Y. & Koyama, H. ENHANCEMENT AND NEUTRALIZATION OF FELINE INFECTIOUS PERITONITIS VIRUS-INFECTION IN FELINE MACROPHAGES BY NEUTRALIZING MONOCLONAL-ANTIBODIES RECOGNIZING DIFFERENT EPITOPES. Microbiology and Immunology 37, 499-504, doi:10.1111/j.1348-0421.1993.tb03242.x (1993).

432    Gilmore, W. & Moradzadeh, D. S. BETA-ENDORPHIN PROTECTS MICE FROM NEUROLOGICAL DISEASE INDUCED BY THE MURINE CORONAVIRUS MHV-JHM. Journal of Neuroimmunology 48, 81-90, doi:10.1016/0165-5728(93)90061-3 (1993).

433    Benkaddour, M., Tache, S., Labie, C., Bodin, G. & Eeckhoutte, M. ROLE OF TEMPERATURE, ACIDIC PH AND LACTIC BACTERIA ON THE STABILITY OF ROTAVIRUS AND CORONAVIRUS IN MILK. Revue De Medecine Veterinaire 144, 709-716 (1993).

434    Baker, S. C., Gao, H. Q. & Baric, R. S. in Coronaviruses: Molecular Biology and Virus-Host Interactions Vol. 342 Advances in Experimental Medicine and Biology (eds H. Laude & J. F. Vautherot)  215-219 (1993).

435    Akerlund, A. et al. MUCOSAL EXUDATION OF FIBRINOGEN IN CORONAVIRUS-INDUCED COMMON COLDS. Acta Oto-Laryngologica 113, 642-648, doi:10.3109/00016489309135878 (1993).

436    Vandermost, R. G., Heijnen, L., Spaan, W. J. M. & Degroot, R. J. HOMOLOGOUS RNA RECOMBINATION ALLOWS EFFICIENT INTRODUCTION OF SITE-SPECIFIC MUTATIONS INTO THE GENOME OF CORONAVIRUS MHV-A59 VIA SYNTHETIC COREPLICATING RNAS. Nucleic Acids Research 20, 3375-3381, doi:10.1093/nar/20.13.3375 (1992).

437    To, L. T. & Bernard, S. EFFECT OF FIXATION ON THE DETECTION OF TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS ANTIGENS BY THE FIXED-CELL IMMUNOPEROXIDASE TECHNIQUE. Journal of Immunological Methods 154, 195-204, doi:10.1016/0022-1759(92)90192-v (1992).

438    Reeves, N. C. P., Pollock, R. V. H. & Thurber, E. T. LONG-TERM FOLLOW-UP-STUDY OF CATS VACCINATED WITH A TEMPERATURE-SENSITIVE FELINE INFECTIOUS PERITONITIS VACCINE. Cornell Veterinarian 82, 117-123 (1992).

439    Oleszak, E. L., Knisley, K., Rodkey, L. S. & Leibowitz, J. L. MICROHETEROGENEITY OF S-GLYCOPROTEIN OF MOUSE HEPATITIS-VIRUS TEMPERATURE-SENSITIVE MUTANTS. Journal of Virological Methods 38, 103-112, doi:10.1016/0166-0934(92)90173-b (1992).

440    Koetzner, C. A., Parker, M. M., Ricard, C. S., Sturman, L. S. & Masters, P. S. REPAIR AND MUTAGENESIS OF THE GENOME OF A DELETION MUTANT OF THE CORONAVIRUS MOUSE HEPATITIS-VIRUS BY TARGETED RNA RECOMBINATION. Journal of Virology 66, 1841-1848, doi:10.1128/jvi.66.4.1841-1848.1992 (1992).

441    Gombold, J. L. & Weiss, S. R. MOUSE HEPATITIS-VIRUS A59 INCREASES STEADY-STATE LEVELS OF MHC MESSENGER-RNAS IN PRIMARY GLIAL-CELL CULTURES AND IN THE MURINE CENTRAL-NERVOUS-SYSTEM. Microbial Pathogenesis 13, 493-505, doi:10.1016/0882-4010(92)90015-g (1992).

442    Fu, K. S. & Baric, R. S. EVIDENCE FOR VARIABLE RATES OF RECOMBINATION IN THE MHV GENOME. Virology 189, 88-102, doi:10.1016/0042-6822(92)90684-h (1992).

443    Fazakerley, J. K., Parker, S. E., Bloom, F. & Buchmeier, M. J. THE V5A13.1 ENVELOPE GLYCOPROTEIN DELETION MUTANT OF MOUSE HEPATITIS-VIRUS TYPE-4 IS NEUROATTENUATED BY ITS REDUCED RATE OF SPREAD IN THE CENTRAL-NERVOUS-SYSTEM. Virology 187, 178-188, doi:10.1016/0042-6822(92)90306-a (1992).

444    Benkaddour, M., Tache, S., Eeckhoutte, M. & Labie, C. METHODS TO CONCENTRATE VIRUSES FROM EXPERIMENTALLY CONTAMINATED MILK – A COMPARATIVE-STUDY. Revue De Medecine Veterinaire 143, 919-926 (1992).

445    Storz, J. et al. MONOCLONAL-ANTIBODIES DIFFERENTIATE BETWEEN THE HEMAGGLUTINATING AND THE RECEPTOR-DESTROYING ACTIVITIES OF BOVINE CORONAVIRUS. Journal of General Virology 72, 2817-2820, doi:10.1099/0022-1317-72-11-2817 (1991).

446    Oneil, S. A., Lappin, M. R., Reif, J. S., Marks, A. & Greene, C. E. CLINICAL AND EPIDEMIOLOGIC ASPECTS OF FELINE IMMUNODEFICIENCY VIRUS AND TOXOPLASMA-GONDII COINFECTIONS IN CATS. Journal of the American Animal Hospital Association 27, 211-220 (1991).

447    Hoskins, J. D. CORONAVIRUS INFECTION IN CATS. Compendium on Continuing Education for the Practicing Veterinarian 13, 567-& (1991).

448    Baric, R. S. et al. MURINE CORONAVIRUS TEMPERATURE SENSITIVE MUTANTS. Vol. 276 (1990).

449    Lamarre, A. & Talbot, P. J. EFFECT OF PH AND TEMPERATURE ON THE INFECTIVITY OF HUMAN CORONAVIRUS-229E. Canadian Journal of Microbiology 35, 972-974, doi:10.1139/m89-160 (1989).

450    Christianson, K. K., Ingersoll, J. D., Landon, R. M., Pfeiffer, N. E. & Gerber, J. D. CHARACTERIZATION OF A TEMPERATURE SENSITIVE FELINE INFECTIOUS PERITONITIS CORONAVIRUS. Archives of Virology 109, 185-196, doi:10.1007/bf01311080 (1989).

451    Koolen, M. J. M. et al. INDUCTION OF DEMYELINATION BY A TEMPERATURE-SENSITIVE MUTANT OF THE CORONAVIRUS MHV-A59 IS ASSOCIATED WITH RESTRICTION OF VIRAL REPLICATION IN THE BRAIN. Journal of General Virology 68, 703-714, doi:10.1099/0022-1317-68-3-703 (1987).

452    Wege, H., Koga, M., Watanabe, R., Nagashima, K. & Termeulen, V. NEUROVIRULENCE OF MURINE CORONAVIRUS JHM TEMPERATURE-SENSITIVE MUTANTS IN RATS. Infection and Immunity 39, 1316-1324, doi:10.1128/iai.39.3.1316-1324.1983 (1983).

453    Robb, J. A., Bond, C. W. & Leibowitz, J. L. PATHOGENIC MURINE CORONAVIRUSES .3. BIOLOGICAL AND BIOCHEMICAL CHARACTERIZATION OF TEMPERATURE-SENSITIVE MUTANTS OF JHMV. Virology 94, 385-399, doi:10.1016/0042-6822(79)90469-0 (1979).

454    Cyranoski, D. Mystery deepens over animal source of coronavirus. Nature 579 265–269 (26 February 2020).

455    Graham, F. Daily briefing: A protein on the surface of the coronavirus might explain why it is so contagious. Nature (9 March 2020).